When formal escalation notices hit the inboxes of New Zealand’s health regulators, oversight commissioners, and ministerial offices, they weren’t asking for superficial tweaks or polite acknowledgement. They were built on a clear, unvarnished demand for systemic accountability regarding the abandonment of women harmed by the Essure permanent contraceptive implant.

The original correspondence laid bare a multi-layered regulatory and clinical crisis. It challenged Medsafe’s passive post-market surveillance—pointing out the absurdity of expecting injured women in New Zealand to self-advocate against a multinational pharmaceutical giant like Bayer while local doctors received zero clinical guidance on symptom identification or safe explantation. It detailed how ACC’s narrow operational focus on acute surgical removal leaves women to shoulder the physical, financial, and psychological burden of chronic trauma without holistic rehabilitation.

Above all, it confronted the stark human rights reality: a healthcare system that permits an 18-year health expectancy gap while quietly shelving dedicated workstreams for device-injured women, violating domestic codes and international conventions alike under CEDAW and ICESCR.

When systematic medical device failures leave women with chronic pelvic pain, organ perforation, heavy metal degradation, and complex auto-immune conditions, you expect public health regulators and oversight bodies to investigate.

Instead, when detailed escalation notices detailing Medsafe’s regulatory void, ACC’s rehabilitation exclusions, and Health New Zealand’s abandoned workstream were lodged across Wellington, what came back?

A masterclass in deflection, automated ticket numbers, and institutional “we don’t care” templates.

Here is how every single agency managed to miss the point of the correspondence.

1. The Portfolio Shuffle: “Not My Responsibility”

Hon Casey Costello (Associate Minister of Health):

• The Response: Recieved the complaint regarding Medsafe’s post-market surveillance failure and immediately transferred the correspondence to David Seymour.
  
• The Reality: Standard ministerial shuffle—pass the file down the hall so no single minister has to answer for regulatory inaction.

Hon David Seymour (Associate Minister of Health):

• The Response: Pointed out that the Medicines Act 1981 has limited post-market requirements and explicitly stated that “It is regarded as the responsibility of medical device suppliers to consider issues and take action as appropriate.” Directed patients back to GPs and noted ACC cover might be available.
  
• The Reality: Completely validated our core complaint. The Minister confirmed that New Zealand’s health system relies on pharmaceutical multinationals (like Bayer) to police themselves, while sending injured women back to primary care doctors who were never given diagnostic or explantation guidelines.

Hon Scott Simpson (Minister for ACC):

• The Response: Hid behind statutory independence, stating he “can neither direct ACC to provide services nor intervene in its decision-making.” Added that expanding ACC cover for Essure causation without fault would raise boundary costs, concluding: “I am not considering making such a change at this time.”
  
• The Reality: Dodged the entire point. ACC regularly approves acute surgical device removal, but systematically denies funded physical rehabilitation, occupational support, and trauma counseling for resulting complex PTSD. The Minister chose scheme liability boundaries over patient recovery.

2. The Statutory Loophole: “We Sympathize, But We Can’t Act”

Te Tāhū Hauora | Health Quality & Safety Commission (HQSC):

• The Response: Written by CEO Prof. Sunny Collings, acknowledging that Essure issues mirror the failures of the Surgical Mesh disaster and UK safety reviews. However, concluded that “the Commission does not have the statutory authority to require Health NZ or other agencies to undertake particular actions… nor can we direct the development of clinical services… Commission is not able to initiate a formal review…”
  
• The Reality: High-level institutional sympathy paired with a total disclaimer of power. They agree the safety signals and consumer voices are being ignored, but declare themselves powerless to do anything about it.

Te Kāhui Tika Tangata | Human Rights Commission:

• The Response: Acknowledged statutory powers to inquire into human rights breaches, listed discretionary criteria, explicitly noted that “the fact that your request is being considered should not be taken as an indication that an inquiry will be commenced,” and stated: “We will now close our file.”
  
• The Reality: A template form letter that cited human rights mandate sections only to close the file without investigating the 18-year health expectancy gap or CEDAW breaches.

3. The Individual Complaint Trap & Automated Silence:

Office of the Health & Disability Commissioner (HDC):

• The Response: Morag McDowell noted she wrote to HealthNZ requesting an update, but reminded that “women have the option of lodging a complaint with the Health and Disability Commissioner if they are concerned about their experience… A link to HDC’s electronic complaint form is included here…”
  
• The Reality: Atomizes a systemic, state-level failure into individual burden. Instead of holding HealthNZ accountable for abandoning its national workstream, HDC tells sick women to file individual complaints against their local doctors.

Medical Council of New Zealand (MCNZ) & HealthNZ National Contact Centre:

• The Response: MCNZ provided a generic acknowledgment that they aim to respond within 15 working days. HealthNZ issued an automated ticket confirmation (NACC-214161) from a Jira support desk.
  
• The Reality: Complete administrative silence. A formal escalation on medical device harm and clinician education was reduced to a IT-style ticket number.

The Bottom Line

Every single agency rolled out the exact same playbook: narrow statutory disclaimers, passing responsibility to another entity, or telling individual patients to navigate the broken system alone.

Not a single state actor addressed the fundamental issue: Health New Zealand abandoned its Essure workstream, Medsafe leaves post-market safety to device manufacturers, and women in Aotearoa are left with zero clinical pathways or rehabilitation support.

This collective circular deflection is precisely why domestic avenues have proven exhausted—and why international oversight bodies like the UN Special Rapporteur on the Right to Health are now reviewing the file.